5 Regions Face Mixed Verdicts as US Rules on $3907 Epoxy Resin Imports
In a pivotal decision on April 30, the U.S. International Trade Commission (ITC) delivered a split outcome for epoxy resin exporters from five countries and regions. The commission ruled that imports from China and India do not threaten or harm domestic producers, effectively ending the anti-dumping and countervailing duty investigations for those two nations.
However, the ITC issued affirmative injury determinations for epoxy resins from South Korea, Thailand, and Taiwan, concluding that these imports materially damage or threaten the U.S. industry. This means the U.S. Department of Commerce will impose anti-dumping duties on products from all three, and countervailing duties on shipments from Korea and Taiwan.
These actions affect products classified under customs code 3907.30.0000, a category widely used in coatings, adhesives, and composites.
The trade review process began on April 23, 2024, when the Commerce Department launched investigations targeting epoxy resins from China, India, Korea, and Taiwan for both dumping and subsidies, and Thailand for dumping alone. On March 31, 2025, the Commerce Department concluded that dumping and subsidization had indeed occurred, but ITC’s latest vote limits the scope of enforcement.
For Chinese and Indian exporters, the ruling brings relief amid increasing scrutiny on chemical exports. But Korean, Thai, and Taiwanese producers now face tariffs that could significantly alter their access to the U.S. market.
The outcome underscores the growing complexity of global chemical trade enforcement and highlights how each region’s practices are being examined with greater precision.
2026-10-28
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
MDI Price Surge Hits EMEAI: Is This a Market Correction or the Beginning of a Supply Crisis?
-
“Deregulation” or “Concession”? The Hidden Crisis Behind India’s Repeal of QCOs on Seven Key Petrochemicals
-
Oil-Coal Price Gap Widens! Coal Chemical Enterprises See Significant Profit Surge in H1 2026
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
Explosions Reported Near Saudi Aramco Headquarters as Missile Is Intercepted Over Dhahran
-
European Petrochemicals Enter 'Era of Downsizing' as Dow, TotalEnergies, Shell Exit Older Cracker Assets
Recommend Reading
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
Canada Scraps PV Module Tariffs! Market Reopens, Demand for Supporting Chinese Chemical New Materials Set to Take Off
-
DKSH Expands Partnership with Assessa to Distribute Botanical Ingredients Across China
-
Two Commercial Ships Confirmed Sunk Near Strait of Hormuz Within 24 Hours
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Premium Global Chemical Sourcing Requests (14 - 18 Mar, 2026)
-
Raw Material Costs Remain High, Melamine Prices Slightly Increase in China
-
January China MIBK Market Shows a Phased Recovery
-
Winter Storms Combined with Geopolitical Tensions Drive Oil Prices Up 3% in a Single Day
-
January ammonium sulfate market trend in China shows a strong increase